Literature DB >> 15693110

Common mechanisms in immune-mediated inflammatory disease.

Gary S Firestein1, Maripat Corr.   

Abstract

Characterization of the K/BxN mouse model of spontaneous arthritis contributed to the rediscovery of immune complex-mediated inflammation in rheumatoid arthritis (RA). Serum from these animals can transfer joint-specific inflammation to normal mice. Fc receptors, interleukin 1, mast cells, and complement are all essential for the development of arthritis after serum transfer. In RA, additional amplifying factors have been identified, including cytokines and intracellular signaling molecules, such as mitogen-activated protein kinases and nuclear factor kappa B, that perpetuate inflammation. Understanding the autoimmune and inflammatory pathways implicated in disease has led to targeted drug development and improved clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15693110

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  5 in total

1.  Immunostimulatory effects of collagen from jellyfish in vivo.

Authors:  Hitoshi Morishige; Takuya Sugahara; Sogo Nishimoto; Ayako Muranaka; Fumi Ohno; Ryusuke Shiraishi; Mikiharu Doi
Journal:  Cytotechnology       Date:  2011-07-20       Impact factor: 2.058

2.  The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.

Authors:  Betty Y Chang; Min Mei Huang; Michelle Francesco; Jun Chen; Jeremy Sokolove; Padmaja Magadala; William H Robinson; Joseph J Buggy
Journal:  Arthritis Res Ther       Date:  2011-07-13       Impact factor: 5.156

3.  Characterization of DC-STAMP+ Cells in Human Bone Marrow.

Authors:  Yahui Grace Chiu; Christopher T Ritchlin
Journal:  J Bone Marrow Res       Date:  2013-07-19

4.  Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy.

Authors:  Alexander Rosenberg; Hongtao Fan; Yahui G Chiu; Rebecca Bolce; Darren Tabechian; Rick Barrett; Sharon Moorehead; Frédéric Baribaud; Hao Liu; Nancy Peffer; David Shealy; Edward M Schwarz; Christopher T Ritchlin
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

5.  Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.

Authors:  Kathleen M Gillooly; Claudine Pulicicchio; Mark A Pattoli; Lihong Cheng; Stacey Skala; Elizabeth M Heimrich; Kim W McIntyre; Tracy L Taylor; Daniel W Kukral; Shailesh Dudhgaonkar; Jignesh Nagar; Dana Banas; Scott H Watterson; Joseph A Tino; Aberra Fura; James R Burke
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.